Answers are grounded in this paper and cite their sources.
Malignant melanoma incidence is increasing, and survival remains poor following metastasis. The main driver oncogenes are BRAF and NRAS. Advancements in targeted agents and immunotherapies have improved survival rates, especially for patients with BRAF mutant melanoma. However, no targeted therapy options are available for patients with NRAS-mutant melanoma. Unfortunately, the development of resistance to all existing therapies remains a challenge. Recent evidence has shown that the MST2/Hippo pathway is deregulated in melanoma. The MST2 pathway core kinase LATS1 is a signalling hub that mediates the crosstalk between cell death and proliferation networks, and its inactivation has been related to melanoma progression and resistance to targeted therapy. However, the mechanisms by which LATS1 influences melanoma biology remain unclear. Here, to investigate this role of LATS1, we developed a lats1 knockout zebrafish melanoma model driven by either BRAF or NRAS mutations. Loss of Lats1 associates with reduced tumour-free survival in BRAF-mutant melanoma and a more invasive phenotype in NRAS-mutant melanoma, confirming a tumour-suppressive function. Integrating transcriptomics and proteomics datasets, we mapped molecular mechanisms mediated by Lats1 in tumours driven by these oncogenes, including pathways associated with the immune response regulated by Lats1. Subsequent validation in patient data confirmed an immune-evasive phenotype, associated with decreased LATS1 expression in BRAF-mutant melanoma. Additionally, the loss of LATS1 in NRAS mutant melanoma patients altered the expression of key DNA damage repair genes. Thus, this study identifies novel pathways controlled by LATS1 in melanoma, which aid in our understanding of the disease and offers new insights to be explored for the development of novel treatment strategies.
No takes yet. Share an insight, caveat, or question.
Aboud et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: